文献速递肝病

评估Sepsis-3标准与快速SOFA在肝硬化合并细菌感染患者中的应用

Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections.
PubMed 文献 · Gut · 2017-08-31

前瞻性纳入259例肝硬化合并细菌/真菌感染患者,评估Sepsis-3与qSOFA对院内死亡的预测能力,并外部验证197例。Sepsis-3与qSOFA的AUROC分别为0.784和0.732,均优于SIRS的0.606(p<0.01)。Sepsis-3(sHR=5.47)和qSOFA(sHR=1.99)为独立预测因子。

要点

  • Sepsis-3与qSOFA对肝硬化感染患者院内死亡的判别能力优于SIRS。
  • Sepsis-3(sHR=5.47;p=0.006)和qSOFA(sHR=1.99;p=0.020)为独立预测因子。
  • 符合Sepsis-3者急性-on-慢性肝衰竭、感染性休克及转入ICU发生率更高。

核心结论

  • Sepsis-3标准在预测肝硬化患者感染严重程度方面较SIRS标准更准确。
  • qSOFA是评估这些患者不良结局风险的实用床旁工具。
  • 符合Sepsis-3且qSOFA阳性的患者需要更密集的管理和严格监测。

研究设计与样本

  • 前瞻性纳入259例连续肝硬化合并细菌/真菌感染患者,诊断感染时收集人口学、实验室和微生物学数据。
  • 基线SOFA使用入院前数据评估,随访至死亡、肝移植或出院。
  • 结果在197例患者中进行外部验证。

主要发现

  • Sepsis-3与qSOFA对院内死亡的AUROC分别为0.784和0.732,均高于SIRS的0.606(两者p<0.01)。
  • 验证队列中观察到相似结果。
  • Sepsis-3(sHR=5.47;p=0.006)、qSOFA(sHR=1.99;p=0.020)、慢性肝衰竭 Consortium 急性失代偿评分(sHR=1.05;p=0.001)和C反应蛋白(sHR=1.01;p=0.034)为院内死亡的独立预测因子。
  • 符合Sepsis-3的患者急性-on-慢性肝衰竭、感染性休克和转入ICU的发生率高于不符合Sepsis-3者。

关键数值与推荐

  • Sepsis-3定义为SOFA较基线增加≥2分。
  • qSOFA定义为意识状态改变、收缩压≤100 mm Hg或呼吸频率≥22次/分中至少两项。

临床怎么用

  • 作者认为,符合Sepsis-3且qSOFA阳性的患者需要更密集的管理和严格监测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Patients with cirrhosis have a high risk of sepsis, which confers a poor prognosis. The systemic inflammatory response syndrome (SIRS) criteria have several limitations in cirrhosis. Recently, new criteria for sepsis (Sepsis-3) have been suggested in the general population (increase of Sequential Organ Failure Assessment (SOFA) ≥2 points from baseline). Outside the intensive care unit (ICU), the quick SOFA (qSOFA (at least two among alteration in mental status, systolic blood pressure ≤100 mm Hg or respiratory rate ≥22/min)) was suggested to screen for sepsis. These criteria have never been evaluated in patients with cirrhosis. The aim of the study was to assess the ability of Sepsis-3 criteria in predicting in-hospital mortality in patients with cirrhosis and bacterial/fungal infections. METHODS: 259 consecutive patients with cirrhosis and bacterial/fungal infections were prospectively included. Demographic, laboratory and microbiological data were collected at diagnosis of infection. Baseline SOFA was assessed using preadmission data. Patients were followed up until death, liver transplantation or discharge. Findings were externally validated (197 patients). RESULTS: Sepsis-3 and qSOFA had significantly greater discrimination for in-hospital mortality (area under the receiver operating characteristic (AUROC)=0.784 and 0.732, respectively) than SIRS (AUROC=0.606) (p<0.01 for both). Similar results were observed in the validation cohort. Sepsis-3 (subdistribution HR (sHR)=5.47; p=0.006), qSOFA (sHR=1.99; p=0.020), Chronic Liver Failure Consortium Acute Decompensation score (sHR=1.05; p=0.001) and C reactive protein (sHR=1.01;p=0.034) were found to be independent predictors of in-hospital mortality. Patients with Sepsis-3 had higher incidence of acute-on-chronic liver failure, septic shock and transfer to ICU than those without Sepsis-3. CONCLUSIONS: Sepsis-3 criteria are more accurate than SIRS criteria in predicting the severity of infections in patients with cirrhosis. qSOFA is a useful bedside tool to assess risk for worse outcomes in these patients. Patients with Sepsis-3 and positive qSOFA deserve more intensive management and strict surveillance.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Piano S, Bartoletti M, Tonon M, et al. Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections. Gut. 2017. PMID: 28860348. doi:10.1136/gutjnl-2017-314324

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。